ADHD Prescriptions Keep Climbing. Help Should Not Wait for a Label

Last updated: July 25, 2026

If you have watched your child struggle to focus and wondered whether to seek an assessment, the newest numbers from England are worth your attention. NHS data reported this week show prescriptions for ADHD medication climbing again, with the sharpest rise among women in their 50s, while more than 800,000 people sit on waiting lists for an assessment. The coverage frames this as a fight about totals: too many prescriptions, or too few. Both sides are arguing about the label. The NHS’s own ADHD Taskforce already answered the question that matters for a family: children should not have to wait for a diagnosis to get help.

TL;DR

ADHD medication prescriptions for women aged 55 to 59 in England rose roughly 40 percent in a year, reaching 4,107 in 2025.

Boys aged 10 to 14 remain the largest group receiving ADHD medication, with 59,111 prescriptions in 2025; girls 15 to 19 rose by more than 5,000 from 18,912 in 2024.

NHS Business Services Authority data show patients prescribed ADHD medication tripled from 107,155 in 2015/16 to 326,450 in 2024/25.

More than 800,000 people are waiting for an NHS ADHD assessment; the independent Taskforce reports waits of 10 to 15 years in some areas.

The Taskforce’s final report recommends needs-led support and says children should not wait for a diagnosis to get help.

ADHD prescriptions in England have tripled in a decade and more than 800,000 people are waiting for an assessment. The NHS’s own taskforce says help for children should not wait for a diagnosis. Here is what that means for your family.

Common questions

Does my child need an ADHD diagnosis to get help at school?

No. The NHS ADHD Taskforce recommends needs-led support, such as coaching, classroom tools, and parenting strategies, offered when a child shows signs of struggle rather than after a diagnosis. In the United States, many schools offer tiered intervention supports on the same principle. Formal accommodations such as an IEP or 504 plan do require a professional evaluation, so pursue one if those supports are what your child needs.

What helps a child with attention struggles while waiting for an assessment?

The Taskforce points to practical, needs-led help: coaching, classroom adjustments, and parenting strategies. At home, that looks like short structured practice sessions that build attention and self-regulation, predictable routines, movement breaks, and consistent sleep. These strengthen the underlying skills whether or not a diagnosis follows, so none of the waiting time is wasted.

Is ADHD overdiagnosed?

Experts disagree. A government-commissioned review has raised concerns about a medicalisation of distress, while researchers writing in the British Journal of Psychiatry counter that diagnosis remains below the condition’s estimated population prevalence, with under-recognition still common, especially in girls and women. Both positions are about national totals. For an individual child, the actionable question is what support they need now, and that question does not wait on the debate.

Should I still get my child formally assessed?

If medication is under consideration, if your child might need formal accommodations such as an IEP or 504 plan, or if you suspect a vision, hearing, or medical cause, a professional evaluation is the route and worth pursuing. A screener is a starting point, not a diagnosis, and it is not meant to replace an evaluation for those formal supports. Its job is to show you where to start building skills today while the formal process runs its course.

ADHD prescriptions in England tripled in a decade. 800,000 people wait for assessment. The NHS's own taskforce says what the headlines skip: children should not wait for a diagnosis to get help. Tweet Now Follow Learning Success

The numbers behind the headlines

NHS prescribing figures reported on July 23 show the number of women aged 55 to 59 prescribed ADHD medication reached 4,107 in 2025, roughly 40 percent more than the year before, with similar growth among women aged 50 to 54. Boys aged 10 to 14 remained the largest group receiving ADHD medication, with 59,111 prescriptions issued in 2025, and the number of girls aged 15 to 19 receiving medication rose by more than 5,000 in a single year, up from 18,912 in 2024.

The longer arc is steeper. NHS Business Services Authority data show 107,155 identified patients on ADHD medication in England in 2015/16 and 326,450 in 2024/25, a tripling in a decade. Women made up 24 percent of those patients ten years ago; they make up 38 percent now. Behind the prescription counts sits a queue: NHS figures show more than 800,000 people waiting for an ADHD assessment, with waits beyond two years common and stretches of 10 to 15 years reported in some areas.

Health Minister Zubir Ahmed acknowledged the strain when the independent ADHD Taskforce published its final report: “Too many are waiting too long to get the ADHD assessment and help they need.”

Author Quote "

Too many are waiting too long to get the ADHD assessment and help they need, which can have a huge impact on their working life

What the coverage gets wrong

The surge headlines invite one question: is this too many prescriptions or too few? That is a debate about national totals, and no family lives in a total. The NHS Taskforce’s own data show both problems at once: prescriptions tripled in a decade while only 25 percent of children with ADHD receive medication and more than 800,000 people wait for assessment. Under-treatment and rising prescribing coexist, so the national argument settles nothing for an individual child. The useful question, the one the Taskforce answered, is whether help has to wait behind the label. It does not.

The fight over the label misses the point

One camp reads these numbers as overdiagnosis. A government-commissioned review chaired by Professor Peter Fonagy is examining what drives rising demand, and its March update pointed to a “medicalisation of distress” and to institutional incentives, noting that a diagnosis is increasingly the gateway to support. The other camp reads the same numbers as decades of missed cases finally surfacing: 32 researchers writing in the British Journal of Psychiatry argue that diagnosis remains substantially below the condition’s population prevalence, which in their view provides no evidence of overdiagnosis at a population level.

Notice what both camps agree on without saying so: the label has become the gate, and the gate has an 800,000-person line in front of it. The independent ADHD Taskforce, chaired by Professor Anita Thapar, put the alternative in plain English in its final report: do not make children wait for a diagnosis to get help. It recommends needs-led support, meaning coaching, classroom tools, and parenting strategies offered when a child shows signs of struggle, whether or not an assessment has happened yet.

The science backs that order of operations. Brain-imaging research from teams at Yale and Stanford shows that struggling learners develop the same neural pathways as their peers after intensive, appropriate practice; the brain you worry about today is not the brain your child will have after six months of the right kind of effort. Skills like attention and self-regulation strengthen through targeted work, and that work needs no permission slip. A diagnosis describes where a child is today. It does not predict where they will be after a year of the right kind of practice. Which means the true cost of the queue is not delayed paperwork. It is a year of skill-building that never starts.

Key Takeaways:

Prescriptions tripled in a decade: NHSBSA data show 107,155 patients on ADHD medication in England in 2015/16 and 326,450 in 2024/25.

The queue is the story: more than 800,000 people wait for an NHS assessment, with waits of 10 to 15 years in some areas.

Help before the label: the NHS Taskforce says children should not wait for a diagnosis to get needs-led support.

What this means for your family

First, start the skills work now. If your child struggles with focus, attention and self-regulation strengthen through structured practice, consistent routines, and support at home. The Taskforce’s needs-led model treats that help as the starting line, not a consolation prize for families stuck in the queue. Waiting for a label before starting is the one strategy the evidence argues against.

Second, keep the assessment appointment if formal supports are on the table. Medication decisions and formal accommodations run through professional evaluation, and the Taskforce’s own figures cut both ways here: research suggests about 5 percent of children have ADHD, yet only a quarter of those children receive medication. Under-recognition and rising prescribing coexist. An assessment brings clarity for some children and unneeded framing for others, so knowing what you want from it before you go is the strongest position a parent holds.

Third, watch the story your child absorbs while the adults argue. A child who hears “we are building your focus skills” walks into practice expecting growth. A child who hears only a waiting-list number learns that something is wrong with them and that help lives somewhere else. The framing at home is the one part of this system a parent fully controls.

Author Quote "

The increase in people receiving an ADHD diagnosis and medication should be celebrated

Parents do not need a national verdict on ADHD numbers before acting for one child. The villain here is not any doctor, researcher, or reviewer. It is the gatekeeping idea that help must wait behind a label, an idea the NHS’s own Taskforce has now rejected in writing. Your child’s brain is building itself this year, queue or no queue, and the practice that shapes it is available at home today. For a clear starting point, our free Learning Difficulties Analysis shows which processing skills need support in minutes, not months. It is a starting point, not a diagnosis, and no substitute for a professional evaluation if your child needs formal accommodations.